พบ "Public health policy"ทั้งหมด 1,233 ผลลัพธ์
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
Abstract
There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that
Leaving No One Behind: Participatory Technology Appraisal as a Platform for Agenda Setting to Address Disparities in Access to Health Services in Thailand.
Abstract
OBJECTIVES:
This article discusses how participatory technology appraisal as part of the Universal Coverage Scheme (UCS) in Thailand contributes to improving access to essential health services among vulnerable populations.
METHODS:
Document review was conducted on health technology
Economic Evaluation of Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Indonesia
Abstract
Background
This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost.
Methods
Based on a societal perspective, a model-based economic evaluation
Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
Abstract
Background
The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to
assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of
TSE in a country with established governance struct
Utilisation of evidence from Thailand’s National Health Examination Survey in policy development: finding the weakest link
Abstract
Background
Health surveillance and survey data are helpful in evidence-informed policy decisions. This study is part of an evaluation of the National Health Examination Survey (NHES) programme in Thailand. This paper focuses on the obstacles in the translation of survey information into
Prevention of non-communicable disease: best buys, wasted buys, and contestable buys
Increasing incidence of non-communicable diseases (NCDs) creates epidemiological and economic burdens everywhere and influences everyone regardless of sex and age.12 Four main NCDs (cardiovascular diseases, diabetes, cancer, and chronic respiratory disease) account for over 12 million premature deat
To include or not include: renal dialysis policy in the era of universal health coverage
SUMMARY POINTS
• End stage renal disease (ESRD) is a life-threatening condition that results in most patients requiring a lifetime of high cost renal dialysis
• Governments have grappled with the political, economic, and ethical challenges of providing treatment with their available budgets
•
How can we make better health decisions: a Best Buy for all?
Abstract
The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) requires them to prioritize health spending. Prioritizing is even more important as low- and middle-income countries transition from external aid. Countries w
Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience
Abstract
India’s rapid economic growth has been accompanied by slower improvements in population health. Given the need to reconcile the ambitious goal of achieving Universal Coverage with limited resources, a robust priority-setting mechanism is required to ensure that the right trade-offs arema
Growth and capacity for cost-effectiveness analysis in Africa
Abstract
As economic evaluation becomes increasingly essential to support universal health coverage (UHC), we aim to understand the growth, characteristics, and quality of cost-effectiveness analyses (CEA) conducted for Africa and to assess institutional capacity and relationship patterns among a
10 / หน้า